- Archives
-
-
-
-
-
-
-
-
-
-
21CFR11 and process validation
Suggy S. Chrai
Some guidelines for sponsor inspections
Margaret B. Voelz
Will a building boom solve the capacity crunch?
Gil Y. Roth
How to take advantage of a CRO’s experience and culture
Douglas J. Squires, Ph.D.
Criteria for optimizing the contract lab experience
Andrew Wood and Gary Deborski
How to clarify what happens after the contract is signed
Tom Handel
Industry insiders discuss the industry’s hot topics
Sarah W. Madley
How will changes in India and China affect API outsourcing?
George Karris
Continuing our series on 21CFR11 compliance
Kevin Lloyd
Continuing our series on 21CFR11 compliance
Susanne Bell
Our annual look at the 20 biggest players in the pharmaceutical marketplace
Our annual look at the top 10 standalone biopharmaceutical companies
A Datamonitor study says big pharma mergers & acquisitions don't add up. What's the solution?
Jennifer Coe
How to get the most from regulator providers
Beverly Lewis
Considerations when outsourcing drug delivery systems
Michael J. Valazza, Cornell Stamoran
Read the results from Contract Pharma's annual salary survey
Gil Roth
Is oral delivery of peptides within reach?
Sarah W. Madley
Rethinking the clinical development model
Vladimir Spehar
Important components of a successful product launch
Frances L. DeGrazio
Tools and strategies for streamlining the process
Natraj Ram, Jennifer L. Bixler and Don R. Durham
Contract Pharma and Nutraceuticals World offer a supplemental issue with articles on Raw Materials Methodology Transfer and Ventilation Enclosures for Dust Containment, as well as an extended Reader Showcase section
James Neal Kababick
Key components in successful pharmaceutical development
Timothy Rhines, Ph.D., Anthony Clemento and Richard Crowley
Specification development and selection
Cliff R. King, Ph.D.
Looking for optimal formulations earlier
Lynne Bartkowski
How to do bioanalytical chemistry the wrong way...
Peter T. Kissinger, Ph.D.
|
